🇺🇸 FDA
Patent

US 10869871

Compositions and methods of modulating short-chain dehydrogenase activity

granted A61KA61K31/4365A61K31/437

Quick answer

US patent 10869871 (Compositions and methods of modulating short-chain dehydrogenase activity) held by The Board of Regents of the University of Texas System expires Mon Dec 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Dec 22 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K31/4365, A61K31/437, A61K31/444, A61K31/496